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A survey was undertaken to investigate the prevalence of high-functioning pervasive developmental disorder (HFPDD) in a
community sample of teenagers and adults aged 13 and above in the city of Sheﬃeld, UK. 112 possible and definite cases were
found, of whom 65 (57%) had a previous diagnosis. The detected prevalence of possible or definite HFPDD was found to be
0.24 per 1000 of the population of Sheﬃeld city aged 13 or over, but the prevalence by year of age fell from a maximum of 1.1
per 1000 in the group aged 13 to 14 years old (1 young adult in every 900 in this age group) to 0.03 per 1000 in the over 60s
(1 person in every 38500 in this age group). The results of this study are preliminary and need follow-up investigation in larger
studies. We suggest several explanations for the findings, including reduced willingness to participate in a study as people get older,
increased ascertainment in younger people, and increased mortality. Another contributory factor might be that the prevalence
of high-functioning pervasive development disorder may decline with age. This raises the possibility that AS symptoms might
become subclinical in adulthood in a proportion of people with HFPDD.
1. Introduction
The UK Government has recently (March 2010) published
a strategy for adults with autism (Fulfilling and rewarding
lives) building on the Autism Act of 2009, and the National
Audit Oﬃce report Supporting people with autism through
adulthood [1]. The “second strand of the strategy” is to
develop a “clear, consistent pathway for [the] diagnosis of
autism.” The strategy also calls for estimates of the numbers
of adults with autism.
Currently the diagnosis and management of adults with
an autism spectrum disorder (an ASD) in combination with
an intellectual disability is the responsibility of learning dis-
ability teams, who have considerable, and well-established,
experience. Responsibility for the diagnosis of people with
an ASD who do not have an intellectual disability is much
less clear, although a recent report of the Royal College of
Psychiatrists in the UK indicated that it can best be carried
out by community mental health teams, not least because
many adults with an ASD seeking diagnosis may have
a comorbid psychiatric disorder. Trainee psychiatrists and
clinical psychologists have been expected to be familiar with
the criteria for the diagnosis of autism for years (unpublished
correspondence to the second author from the board of
examiners of the UK Royal College of Psychiatrists, and the
British Psychological Society), but people seeking a diagnosis
of ASD are regularly turned away from mental health teams
because they lack training.
Community mental health teams may also argue that
they are not commissioned to provide diagnosis or man-
agement, but this is likely to change once the strategy is
implemented. Community mental health teams are hard
pressed in the UK and everywhere in the developed world.
Team members may be reluctant to accept responsibility for
adults with an ASD but no learning diﬃculty considering
the rising prevalence of children identified with an ASD
over the last decade, with prevalence estimates currently
reaching those of schizophrenia, that is, 1% of the population
(Baird et al.). This rise in reported prevalence has been
much greater in those without an intellectual disability, who
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now account for about half of those with a diagnosis of
an ASD.
It is commonly assumed that these prevalence figures,
which have all been based on surveys of children, also apply
to adults. If that were so, then 0.3% of adults with no
intellectual disability would have an ASD and any of them
who have not previously had a diagnosis might turn to the
community mental health team for a diagnostic assessment.
Inevitably some people who were diagnosed as children may
want the diagnosis to be reviewed and may also turn to the
community mental health team for services or advice.
How big a demand will this be? Are colleagues right to
fear that they will be inundated, as some do?
We have surveyed all residents of Sheﬃeld aged 13 and
over who may have or are known to have an ASD but
do not have an intellectual disability, and we consider here
estimates of the demand for diagnosis, for treatment of
comorbid psychiatric disorder, and for social care based on
our findings.
2. Background
2.1. Diagnosis. High-functioning pervasive developmental
disorder (HFPDD), also known as Asperger’s syndrome, is
an autistic spectrum condition characterised by “qualitative
abnormalities of reciprocal social interaction that typify
autism, together with a restricted, stereotyped, repetitive
repertoire of interests and activities” [2]. This definition,
taken from the International Classification of Disease, is
accompanied by a description of the disorder, which includes
that suggestion that “at least some cases represent mild
varieties of autism” but the definition of HFPDD in the most
recent Diagnostic and Statistical Manual of mental disorders
[3] states that a diagnosis of HFPDD cannot be made if
a diagnosis of autistic disorder is applicable. It has been
pointed out that the application of this criterion makes it
almost impossible to receive a diagnosis of HFPDD using
DSM-IV criteria [4]. No criteria have been found to separate
autistic disorder and HFPDD [5–9] other than symptom
severity. When diﬀerences are found they can often be
attributed to the fact that children with language impairment
are included in the autistic disorder group and excluded
from the HFPDD group [10], but language impairment
often remits in late childhood in the more able group. The
term “high-functioning autistic disorder” is also used in
the USA for those people with autistic disorder who have
less severe symptoms and we have assumed in this study
that HFPDD, Asperger’s syndrome, Asperger’s disorder, and
high-functioning autistic disorder are synonymous and that
they are diﬀerentiated from other autistic disorders by an
absence of current language or cognitive impairment. We
have therefore used HFPDD and high-functioning autism
(HFA) interchangeably and have included in our study all
those with a pervasive developmental disorder in the absence
of an intellectual disability.
2.2. Prevalence. For decades autism (of all subtypes) was
considered to be a rare condition with a low prevalence
of approximately 2–4 per 10,000 children [11]. Recent
epidemiological research suggests that the prevalence of
autistic spectrum disorders may be much higher than
previously thought [12], possibly up to 20–30 per 10,000
[13]. It is unclear whether autism spectrum disorders are
themselves increasing in prevalence; however, it is thought
that changes in diagnosis and criteria [14], together with
improved awareness of ASDs among diagnostic teams and
clinicians, have contributed to this increase [13].
Within the context of this overall increase, the prevalence
of HFPDD is considered to be lower than that of other
autistic disorder subtypes [13], possibly as low as 2.5 per
10,000 if conservative estimates are employed [15]; though,
some studies have found a higher prevalence of HFPDD of
up to 9.2 per 10,000 [14]. Males predominate individuals
diagnosed with HFPDD more than they do individuals
diagnosed with traditional autism [14]. There are alternate
explanations for the lower prevalence rate of HFPDD: one
may be that HFPDD is simply less common than other
forms of ASD; it may also be that it is underrecognized in
children with normal intelligence, whose intellectual abilities
can disguise their underlying PDD [16]. It may also be
that the research base is simply lacking due to the face that
HFPDD was only recently included as a diagnostic category
in DSM and ICD-10 [17].
Most ASD prevalence studies base their estimates on
figures derived from child populations [12, 15]. This makes
practical sense; childhood is when ASD behaviors are likely
to manifest themselves most clearly; children are also subject
to surveillance by a range of health, education, and social
services that can pick up signs of ASD. The consequence
of this child-centered approach to prevalence, however, is
that there is very little research into estimating prevalence
in adults with HFPDD. This is potentially an important
absence; even within child populations estimates of HFPDD
can vary depending on when children are assessed—
estimates obtained in younger samples might underestimate
the prevalence of HFPDD compared to estimates derived
from children in their early teens [18]. It may well be that
HFPDD prevalence can also change as children grow older,
either increasing or, perhaps, decreasing. However, since few
studies to date have examined adult HFPDD prevalence, it
is unknown whether childhood prevalence figures stay static
into adulthood or changes.
3. Methods
3.1. Sample. We surveyed adolescents aged 13 and above
along with adults living in the city of Sheﬃeld who had either
received a clinical diagnosis of a high-functioning autism
spectrum disorder/pervasive developmental disorder or who
met research criteria for high-functioning ASD, that is a
characteristic developmental profile plus current social and
communicative impairment using a standard observational
scale.
To recruit adolescents we wrote to all headmasters in
Sheﬃeld asking them to draw the study to the attention of
school educational needs coordinators and the pupils for
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whom they were responsible. Because of ethical considera-
tions we could not use school records or obtain information
from the local education authority. We sent letters to every
general practice in Sheﬃeld, to all neurologists, paedia-
tricians and community paediatricians, and psychiatrists,
inviting them to bring the study to the attention of any
of their patients who had, or whom they suspected of
having, high-functioning pervasive developmental disorder
(also known as Asperger, syndrome or high-functioning
Autism).
To increase the recruitment of adults and older ado-
lescents, especially those without a previous diagnosis, we
designed posters to invite people to participate if they had
life-long diﬃculties in making friends. We placed posters in
supermarkets, shops, cinemas, post oﬃces, libraries, pubs,
workplaces, student noticeboards, employment assistance
agencies, and GP practices throughout the city. We wrote
articles for the local Sheﬃeld Star and Sheﬃeld Tele-
graph (the local newspapers with the highest circulation in
Sheﬃeld), and gave an interview on Radio Sheﬃeld about
the study; this interview was subsequently hosted on the
main BBC news website. We recruited respondents through
the Sheﬃeld Asperger’s Parents Action Group (SAPAG).
We placed information about the project to the Sheﬃeld
“Prospects” oﬃce (the employment agency for people with
autism in Sheﬃeld) and sent information about the study
to social workers, care workers, and disability workers
throughout Sheﬃeld.
3.2. Measures. All potential participants were asked about
place of residence and age. Children younger than 13 years,
those living outside the city of Sheﬃeld, and those who
had previous psychometric testing showing that they had an
IQ below 70 were excluded. The remainder were sent the
Autism SpectrumQuotient (AQ), a 50-item autism screening
instrument developed by Baron-Cohen et al. [19]. Baron-
Cohen et al. suggest that 26 is a valid cut-oﬀ point for
distinguishing likely autistic behaviour from non-autistic
[20]. Participants were also asked for additional consent to
be interviewed and for their parents to be interviewed. They
were assessed using a specially devised observational scale
of communicative impairment [21] in place of the more
usual ADOS that had not been validated in adults [22] at
the time of the survey, and the Wechsler Abbreviated Scale
of Intelligence (WASI) [23]. Their parents were interviewed
using the revised Autism Diagnostic Interview (ADI-R)
[24] by a research worker trained in its use who was
unaware of the participant’s AQ scores at the time of the
interview.
The North Sheﬃeld Local Research Ethics Committee
granted the project ethical approval and all respondents gave
written informed consent.
4. Results
151 people from Sheﬃeld contacted the research team and
were sent an AQ and a questionnaire. The questionnaire
asked respondents for their address in Sheﬃeld and whether
Table 1: The concordance of clinical diagnosis and ADI-R scores
above threshold.
Previous diagnosis of HFPDD
ADIR+ 24
ADIR− 2
or not they had a clinical diagnosis of AS. 120 (out of 151)
AQs were returned. Six of these participants were excluded
from the prevalence study because their AQ scores were
below threshold and they had no previous diagnosis of PDD,
and 2 were excluded because their addresses were outside the
city boundary.
Only 23 participants (out of the 120 who returned AQs)
agreed to be interviewed and to complete a WASI, and
only 36 allowed their parents to be interviewed although,
as no parent refused, ADI-R data were obtained on all of
these 36 participants. Twenty of the completed WASIs were
scored above 70: the three who scored below 70 had been
assessed previously by a clinician as diagnosed as having
high-functioning autism.
Of the 36 participants whose parents completed the
ADI-R, 26 had previously been given a clinical diagnosis of
HFPDD disorder and there was good concordance between
a diagnosis and having an ADI-R score above threshold. We
therefore felt confident about relying on clinical diagnosis as
an indication of “definite HFPDD” (see Table 1).
Although there was 72% agreement between an above
threshold ADI-R score and an AQ above 26 (Table 2), the
kappa was zero as there was a substantial degree of false
positives and false negative findings using the AQ.
Because of the good concordance between a clinical
diagnosis of HFPDD (usually made by a local, specialist ASD
team) and ADI-R score above threshold, we included all
respondents who reported that they had a clinical diagnosis.
There were 65 participants in this definite group. In addition
there were 49 participants with AQ scores over threshold
(score = 26 or above) that we considered to “possibly” have
ASD although we recognize that this criterion probably over-
estimates the numbers with ASD.
We calculated the prevalence using the rates of Sheﬃeld
residents in each age and gender group available from the
national census (Oﬃce of National Statistics, accessed 2007)
in the definite group (Tables 1 and 2).
We calculated prevalence for each age group. There was
a fall with age for participants, for women (see Table 3) but
particularly for men (see Table 4 and Figure 1).
We also plotted the frequency of participants with a
definite or probable diagnosis of HFPDD by postal district of
residence. This showed that participants from many districts
of Sheﬃeld were underrepresented and that the largest
number of participants lived in Sheﬃeld 8, followed by S11
and S6. These areas are described in the Acorn classification
of UK postcodes as including the wealthy or the comfortably
oﬀ.
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Table 2: The correlation between ADI-R and AQ.
AQ ≥ 26 AQ < 26
ADIR+ 25 5
ADIR− 5 1
0
0.5
1
1.5
2
2.5
3
3.5
4
13
/1
4
15
–1
9
20
–2
4
25
–2
9
30
–3
4
35
–3
9
40
–4
4
45
–4
9
50
–5
4
55
–5
9
>
59
Possible or definite
Definite diagnosis
Figure 1: Age-related prevalence of HFPDD in males per 1000
population of the city of Sheﬃeld in that age group.
5. Discussion
5.1. Summary. The prevalence of HFPDD has varied from
study to study, with more recent studies tending to report
greater prevalence averaging out at about 0.6% for the
prevalence of all autistic spectrum disorders, including AS
[15]. The rate of Asperger’s disorder in one community
study of 3–10-year olds, where the prevalence of ASD was
found to be 0.67%, was 0.27% [15]. Many adults will
have missed diagnosis during their childhood [20]. Most
of the studies that have attempted to calculate prevalence
have done so using children (Fombonne and Tidmarsh,
2003). We conducted a study to examine the prevalence of
HFPDD in an adult and adolescent (aged 13 and above)
community sample in Sheﬃeld in the UK. Sheﬃeld is the
fourth biggest city in England, with a population of 435,000
13 and older (figures taken UK Oﬃce of National Statistics
2001 population figures for Sheﬃeld). We considered the
lifetime risk for all those 13 and above.
5.2. Strengths and Weaknesses. This is the first community-
based epidemiological study to attempt to map the preva-
lence of HFPDD in adults. We did not rely on previous
diagnosis or professional ascertainment but invited members
of the public to come forward through a public awareness
campaign. We were therefore able to capture Sheﬃeld
residents who had never been diagnosed, and in the event,
almost half of the adolescents and adults that were included
were not previously known to have an autistic spectrum
disorder.
Including people not previously known to services as
having an ASD was a strength of our recruitment method,
but it also the weakness that some people with AS may not
have heard about the study, or if they did, may not have
been willing to come forward. It is likely that there was a
selection bias influencing those participants who did come
forward and, therefore, that we have underestimated the
prevalence of AS. For instance there is also an underrepre-
sentation of nonwhite groups in our study, and an uneven
geographical distribution of the addresses of our respondents
with many more respondents from south rather than north
Sheﬃeld.
Unlike several previous epidemiological prevalence stud-
ies that were conducted with children [16], we were not able
to intensively screen all study respondents.
5.3. A Possible Fall in Prevalence with Age? The ICD-10
description of Asperger’s syndrome includes the following:
“There is a strong tendency for the abnormalities to persist
into adolescence and adult life. . .” [2, page 258]. DSM-IV
is more definite, stating firmly that “Asperger’s disorder is a
continuous and lifelong disorder” [3, page 82]. The impli-
cations of this are far-reaching. For one, a child diagnosed
with HFPDD can expect, as can their family, that there will
be no escape from social impairment, ever. Asperger was not
of this opinion himself, arguing that autistic psychopathy had
a “good prognosis.” It is diﬃcult to know on what evidence
the assumption that it is a lifelong disorder is based. In the
Goteborg study mentioned earlier [14] the prevalence rate in
the 1989–1994 age cohort (children who were between 7 and
12 at the time of the sample) was 6.8 per 1000, the rate in
children from 13 to 18 was 15.1 per 10000 but the rate in the
adults (aged 19 to 24) was 7.0 per 10000. A similar pattern
of a falling prevalence in age, although of all children with
an ASD and at an earlier age, was reported in a much larger
study in the the USA [25].
The overall prevalence rate that we found, 2.4 per 10,000,
is below the prevalence rate of 9.5 per 10 000 suggested by
some recent estimates of the rate in children [16] and below
that of the adult rate of 7 per 10 000 reported by Gillberg
et al. [14]. However, like Gillberg et al., we found that rates
fell with chronological age and the mean prevalence in our
youngest two age groups, of 13- and 14-year olds, was 11 per
10 000 and therefore comparable to other studies.
The fall in prevalence with age was also shown by the
group who had previously received a clinical diagnosis,
suggesting that it might not be an artefact of self- or
parent overrecognition of HFPDD. It was also found in
the not diagnosed group, too, suggesting that it was not a
consequence of the diagnosis being available in young people
consulting child and adolescent mental health services or in
an increase in rates of diagnosis made by these services over
the last ten years (see Figure 1).
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Table 3: Distribution of females with possible or definite diagnosis of HFPDD by age.
AQ = 26–31 and no
clinical diagnosis
AQ ≤ 32 and previous
clinical diagnosis
AQ ≥ 32 and previous
clinical diagnosis
AQ ≥ 32 and no
previous clinical
diagnosis
Total included with
possible or definite
ASD
13 to 14 1 1 2
15–19 1 1 2
20–24
25–29 1 2 2 5
30–34 1 3 1 3 8
35–39 3 3
40–44 2 2
45–49 1 1
50–54 1 1
55–59 1 1
60 and over 1 1 2
Table 4: Distribution of males with possible or definite diagnosis of HFPDD by age.
Age group AQ = 26–31and no
clinical diagnosis
AQ ≤ 32 and previous
clinical diagnosis
AQ ≥ 32 and previous
clinical diagnosis
AQ ≥ 32 and no
previous clinical
diagnosis
Total included with
likely or confirmed
ASD
13 to 14 2 5 4 1 12
15–19 1 10 11 4 28
20–24 3 1 2 2 8
25–29 3 2 2 7
30–34 3 8 3 14
35–39 1 1 1 1 4
40–44 3 2 1 6
45–49 2 3 5
50–54 1 1
55–59 1 1
60 and over 1 1
5.4. Alternative Explanations for Results. The numbers in the
cells are small, and there are other possible explanations
of this apparent fall. One is that parents are instrumental
in discovering about, and facilitating their children’s par-
ticipation in, community activities, including surveys of
this kind. Adults may therefore be less likely to participate
because they are less influenced by, or less in contact with,
their parents, although our survey also showed that many
of our participants continued to live with their parents
[26]. Other possible reasons for attrition include mortality
and institutionalization and therefore inaccessibility to a
community-based survey. Some individuals with HFPDD
may simply have not been aware that the project was
taking place, despite our best eﬀorts; mapping respondents
postcodes reveals that most respondents came from a few
central areas of Sheﬃeld and that outlying postal districts
were underrepresented.
Adults may also be reluctant to take part in a study such
as this for fear of being labelled as having a disability or a
mental health problem.We had some evidence of the latter in
that some of the women who participated in the early phases
of the study were unwilling to be interviewed because they
had met new partners whom they did not want to tell of their
(possible) condition.
The likelihood that children with HFPDD are diagnosed
has increased substantially since HFPDD was first oﬃcially
recognized. This would be reflected in an apparent reduction
in the prevalence of older people with known HFPDD in
the general population and is perhaps the most economical
explanation of the apparent fall in prevalence, where it not
for the fact that the fall was also seen in the undiagnosed
group, who would not be influenced by this ascertainment
eﬀect.
It is likely that this study has not captured everyone with
high-functioning autism in Sheﬃeld (previous community
prevalence studies of children acknowledge that it is highly
unlikely that everyone with AS in a community will be
captured by one study [27]. The spatial distribution of
diagnosis suggests that ascertainment was highest in the
wealthier parts of the city (see Figure 2).We do not propose it
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(km)
Number of study participants with a
possible or definite ASD diagnosis
Figure 2: Spatial distribution by postcode of HFPDD cases in the city of Sheﬃeld (greater Sheﬃeld postcodes outside city are shown as
white).
as suﬃcient evidence that HFPDD/ HFA may remit in adult
life, although we do consider that the evidence provides a
hypothesis that it may do so.
5.5. Implications. Despite the limitations of this study, ours is
the first community study of HFPDD in adults and it suggests
that there may be a fall in prevalence of HFPDD with age,
consistent with Asperger’s original statement that “autistic
psychopathy,” as he termed HFPDD disorder, has a “good
prognosis” [28]. This finding is perhaps supported by the fact
that no person older than 65 decided to participate in this
study (although one of us—DT—has seen several people in
their 70s in his clinic suggesting that people of this age may
still seek a diagnosis). The possibility that HFPDD remits
with age should not be a surprise since it is exactly the pattern
seen in attention deficit hyperactivity disorder with which
HFPDD has many overlaps [29].
Our findings need replication in larger longitudinal
studies but if, true, have important clinical implications.
One is that eﬀorts to increase the rate of this spontaneous
remission are worthwhile. People with HFPDD are often
satisfied with the help that they receive from health services
[26]. Unfortunately, in many cases very little help is available
for people with high-functioning pervasive developmental
disorder [30].
Another implication is that we may need to consider
more carefully whether HFPDD is a more variable disorder
than is normally thought. Although its basis is neurodevel-
opmental, it is possible that, like other neurodevelopmental
conditions, the functional impairment varies according to
social, emotional, or cognitive demand. Childhood is a time
of considerable social and emotional demand, and it is
possible that the remission of AS in adulthood is partly a
consequence of the remission of this social demand. The
clinical significance of this would be that, if true, then it could
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be expected that AS might apparently “recur” at some later
stage when there is a surge of further demand.
We do think that the results of this study are evidence
that the fear that adult mental health services will be over-
whelmed by a tide of demand if they accept responsibility
for the recognition and treatment of HFPDD is groundless.
Most of the participants in the present study had already
received a diagnosis. So even if screening were instituted,
based on the findings of this study the demand for diagnosis
would be increased by less than a factor of 2. Followup of our
participants often indicated that many did not want further
services and were satisfied with the services that they had
received. Other participants did not want to receive a formal
diagnosis. So it is likely that the true immediate demand on
services would be less even than this.
Finally, we would acknowledge again that, while our
figures may not be completely representative of the universe
of people with HFPDD, they may more accurately reflect
those for whom AS causes significant social impairment. Our
figures do make a strong case for having more definitive
surveys, both to see if our findings are replicated and because
if AS does become less prevalent with age there are important
and obvious implications for services and for the science of
HFPDD aetiology. Future studies will need not only need
to use a door-to-door method of ascertainment (although
even this will miss people with HFPDD who are homeless,
in institutions, or living alone and reluctant to answer the
door) to assess prevalence (since there is no equivalent in
adult life to the school record of pupils with diﬃculties),
but also to have more up-to-date methods of assessing
social impairment which reflected not just objective role
performance (e.g. working, living independently, and so
on) but also subjective assessment of the quality of social
inclusion and participation.
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